As of April 30, 2025, PaxMedica (PXMD) has a market cap of $12,563 Dollars USD. According to our data, PaxMedica is ranked No.9314 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $12,563 Dollars |
-98.13%
|
Dec 31, 2024 | $0.67 M |
-91.85%
|
Dec 29, 2023 | $8.24 M |
-97.81%
|
Dec 30, 2022 | $0.38 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Jazz Pharmaceuticals
JAZZ
|
$7.17 B |
-0.000 M
|
![]() Ireland
|
![]() Corbus Pharmaceuticals
CRBP
|
$88.07 M |
0.000 M
|
![]() USA
|
![]() Cara Therapeutics
CARA
|
$24.33 M |
0.000 M
|
![]() USA
|
![]() Axsome Therapeutics
AXSM
|
$5.36 B |
0.000 M
|
![]() USA
|
![]() Sage Therapeutics
SAGE
|
$0.48 B |
-0.000 M
|
![]() USA
|
![]() Marinus Pharmaceuticals
MRNS
|
$30.37 M |
0.028 M
|
![]() USA
|
![]() BioXcel Therapeutics
BTAI
|
$10.88 M |
0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() ACADIA Pharmaceuticals
ACAD
|
$2.41 B |
0.000 M
|
![]() USA
|
![]() Minerva Neurosciences
NERV
|
$12.06 M |
0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.74 B |
0.000 M
|
![]() Ireland
|
![]() Neurocrine Biosciences
NBIX
|
$10.61 B |
-0.000 M
|
![]() USA
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.81 B |
0.000 M
|
![]() USA
|
Market Cap | = | PXMD Stock Price | * | PXMD Shares Outstanding |
= | $0.00 | * | 0.13 B | |
= | $12,563 Dollars |